Nyxoah to Participate in Upcoming Investor Conferences Mont-Saint-Guibert, Belgium – September 5, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in three […]

WASHINGTON, Sept. 05, 2024 (GLOBE NEWSWIRE) — EB5 Capital is pleased to announce the first two I-526E petition approvals for investors in its SouthFace Village at Okemo (JF36) project. An I-526E approval is a significant step in the EB-5 immigration process as it qualifies the investor and their eligible immediate family members for conditional permanent […]

WASHINGTON, Sept. 05, 2024 (GLOBE NEWSWIRE) — EB5 Capital is pleased to announce the first two I-526E petition approvals for investors in its SouthFace Village at Okemo (JF36) project. An I-526E approval is a significant step in the EB-5 immigration process as it qualifies the investor and their eligible immediate family members for conditional permanent […]

WASHINGTON, Sept. 05, 2024 (GLOBE NEWSWIRE) — EB5 Capital is pleased to announce the first two I-526E petition approvals for investors in its SouthFace Village at Okemo (JF36) project. An I-526E approval is a significant step in the EB-5 immigration process as it qualifies the investor and their eligible immediate family members for conditional permanent […]